中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 4
Apr.  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(4): 650-660

Construction of an evaluation scale for non-alcoholic fatty liver disease with internal retention of dampness and turbidity based on the method of combining disease and syndrome

DOI: 10.12449/JCH250409
  • 1.

    Department of Spleen，Stomach，Liver and Gallbladder Diseases，The First Affiliated Hospital of Henan University of Chinese Medicine，Zhengzhou 450000，China

  • 2.

    Department of Oncology and Hematology，Wenzhou Hospital of Integrated Traditional Chinese and Western Medicine，Wenzhou，Zhejiang 325000，China

Research funding:

National Natural Science Foundation of China (81473651);

Special Project for Scientific Research on Traditional Chinese Medicine in Henan Province (2019JDZX2051);

Special Project for Scientific Research on Traditional Chinese Medicine in Henan Province (2019JDZX2012);

Special Project for Scientific Research on the Creation of “Double First-class” Traditional Chinese Medicine in Henan Province (HSRP-DFCTCM-2023-8-16)

More Information
  • Corresponding author: ZHAO Wenxia， zhao-wenxia@163.com （ORCID： 0000-0002-0592-3504）
  • Received Date: 2024-08-05
  • Accepted Date: 2024-10-08
  • Published Date: 2025-04-25
    Abstract
  •   Objective  To develop a scale for evaluating the syndrome of internal retention of dampness and turbidity in nonalcoholic fatty liver disease （NAFLD） that combines disease and syndrome and has the characteristics of traditional Chinese medicine （TCM）.  Methods  An item pool was established for evaluating the syndrome of internal retention of dampness and turbidity in nonalcoholic fatty liver disease （NAFLD） with reference to the guideline for developing international scales. A clinical survey was conducted among the outpatients and inpatients who were diagnosed with NAFLD and had the syndrome of internal retention of dampness and turbidity in Department of Hepatology and Spleen-Stomach， The First Affiliated Hospital of Henan University of Chinese Medicine， from June to August， 2023， and the items were screened based on the classical test theory and the item response theory. An expert questionnaire was developed， and expert discussions were conducted using the Delphi method to identify the items for evaluating the syndrome of internal retention of dampness and turbidity in NAFLD. Finally， the scale was given scientific scores.  Results  A preliminary item pool was established， with 16 primary items and 22 secondary items， and it was divided into the two dimensions of disease and syndrome type. Clinical pre-survey suggested to retain 9 primary items and 14 secondary items， while the Delphi expert questionnaire recommended to retain 11 primary items and 15 secondary items， and tongue manifestation and pulse manifestation were no longer used for assessing the severity of syndrome. After hierarchical analysis and scientific assignment of scores， the scale for evaluating the syndrome of internal retention of dampness and turbidity in NAFLD had a total score of 123 points and 9 important items， i.e.， discomfort in the hypochondrium， abdominal fullness and distension， obesity， heaviness of the head and body， loose stool， anorexia， coughing up phlegm， nausea with a tendency to vomit， and lethargy.  Conclusion  A preliminary scale is established for evaluating the syndrome of internal retention of dampness and turbidity in NAFLD， which fills the gap in this research field and provides a basis for further clinical application.

     

    • FullText(HTML)
  • loading
    • References(21)
  • [1]
    National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association, Fatty Liver Expert Committee, Chinese Medical Doctor Association. Guidelines of prevention and treatment for nonalcoholic fatty liver disease: A 2018 update[J]. J Clin Hepatol, 2018, 34( 5): 947- 957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组, 中国医师协会脂肪性肝病专家委员会. 非酒精性脂肪性肝病防治指南(2018年更新版)[J]. 临床肝胆病杂志, 2018, 34( 5): 947- 957. DOI: 10.3969/j.issn.1001-5256.2018.05.007.
    [2]
    ZHOU JH, ZHOU F, WANG WX, et al. Epidemiological features of NAFLD from 1999 to 2018 in China[J]. Hepatology, 2020, 71( 5): 1851- 1864. DOI: 10.1002/hep.31150.
    [3]
    YOUNOSSI ZM. Non-alcoholic fatty liver disease- A global public health perspective[J]. J Hepatol, 2019, 70( 3): 531- 544. DOI: 10.1016/j.jhep.2018.10.033.
    [4]
    JI G. Chinese medicine treatment non-alcoholic fatty liver disease knocked international academic door[J]. Chin J Integr Tradit West Med Liver Dis, 2021, 31( 6): 484- 488. DOI: 10.3969/j.issn.1005-0264.2021.06.002.

    季光. 中医药治疗非酒精性脂肪性肝病敲响国际学术大门[J]. 中西医结合肝病杂志, 2021, 31( 6): 484- 488. DOI: 10.3969/j.issn.1005-0264.2021.06.002.
    [5]
    Diagnosis and Treatment Center of Hepatology of South China Alliance of TCM, National Administration of Traditional Chinese Medicine. Diagnosis and treatment scheme of Ganpi(non-alcoholic steatohepatitis)[J/OL]. Chin J Liver Dis Electron Version, 2021, 13( 1): 1- 9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.

    国家中医药管理局华南区中医肝病诊疗中心联盟. 肝癖(非酒精性脂肪性肝炎)诊疗方案[J/OL]. 中国肝脏病杂志(电子版), 2021, 13( 1): 1- 9. DOI: 10.3969/j.issn.1674-7380.2021.01.001.
    [6]
    ZHENG XY. Guidelines for Clinical Research of Chinese Medicines[M]. Beijing: China Medical Science and Technology Press, 2002.

    郑筱萸. 中药新药临床研究指导原则: 试行[M]. 北京: 中国医药科技出版社, 2002.
    [7]
    HE TT, QIAN YL, FANG NY, et al. Systematic evaluation and meta-analysis of Chinese medicine combined with silymarin in treatment of NAFLD[J]. J Pract Tradit Chin Intern Med, 2024, 38( 1): 89- 95, 153- 157. DOI: 10.13729/j.issn.1671-7813.Z20222528.

    何婷婷, 钱涯邻, 方南元, 等. 中医药联合水飞蓟宾治疗非酒精性脂肪性肝病(NAFLD)系统评价与Meta分析[J]. 实用中医内科杂志, 2024, 38( 1): 89- 95, 153- 157. DOI: 10.13729/j.issn.1671-7813.Z20222528.
    [8]
    CHEN GF, GUO J. Clinical observation on the treatment of non-alcoholic fatty liver disease(liver depression and spleen deficiency syndrome) by Strengthening Spleen and Shredding Liver Formula[J]. Guangming J Chin Med, 2019, 34( 10): 1520- 1522. DOI: 10.3969/j.issn.1003-8914.2019.10.023.

    陈高峰, 郭静. 健脾疏肝方治疗非酒精性脂肪肝(肝郁脾虚证)临床观察[J]. 光明中医, 2019, 34( 10): 1520- 1522. DOI: 10.3969/j.issn.1003-8914.2019.10.023.
    [9]
    ZHOU YW, WANG JH, ZHENG JP, et al. Evaluation of CT quantitative efficacy of blood-activating and lipid-lowering formula in the treatment of nonalcoholic fatty liver[J]. Mod J Integr Tradit Chin West Med, 2018, 27( 9): 975- 977. DOI: 10.3969/j.issn.1008-8849.2018.09.018.

    周烨威, 王继海, 郑井平, 等. 活血降脂方治疗非酒精性脂肪肝的CT定量疗效评价[J]. 现代中西医结合杂志, 2018, 27( 9): 975- 977. DOI: 10.3969/j.issn.1008-8849.2018.09.018.
    [10]
    CAI XQ, CAI YY, XIE HD. Clinical observation of 124 cases of nonalcoholic fatty liver disease treated with modified two Chen four ingredients decoction[J]. World Chin Med, 2017, 12( 2): 285- 288. DOI: 10.3969/j.issn.1673-7202.2017.02.012.

    蔡小旗, 蔡媛媛, 谢红丹. 加减二陈四物汤治疗非酒精性脂肪肝124例临床观察[J]. 世界中医药, 2017, 12( 2): 285- 288. DOI: 10.3969/j.issn.1673-7202.2017.02.012.
    [11]
    ZENG MM, YIN X. The distribution regularitie of TCM syndromes of nonalcoholic fatty liver disease[J]. J Shanxi Coll Tradit Chin Med, 2016, 17( 2): 41- 42. DOI: 10.3969/j.issn.1000-7369.2016.02.015.

    曾明明, 殷鑫. 非酒精性脂肪性肝病中医证候分布规律初探[J]. 山西中医学院学报, 2016, 17( 2): 41- 42. DOI: 10.3969/j.issn.1000-7369.2016.02.015.
    [12]
    Branch of Gastrointestinal Diseases, China Association of Chinese Medicine. Expert consensus on Chinese medicine diagnosis and treatment of non-alcoholic fatty liver disease(2023)[J]. Chin J Integr Med and Dig, 2024, 32( 1): 1- 7. DOI: 10.3969/j.issn.1671-038X.2024.01.01.

    中华中医药学会脾胃病分会. 非酒精性脂肪性肝病中医诊疗专家共识(2023)[J]. 中国中西医结合消化杂志, 2024, 32( 1): 1- 7. DOI: 10.3969/j.issn.1671-038X.2024.01.01.
    [13]
    LI YN, FAN G, GENG QS. Researches on the index system of medical students’ professionalism evaluation based on the Delphi and comprehensive evaluation methods[J]. Chin Health Serv Manag, 2020, 37( 6): 467- 471, 480.

    李雅妮, 范耿, 耿庆山. Delphi法和综合考评法在医学生职业素养评价指标体系中的应用研究[J]. 中国卫生事业管理, 2020, 37( 6): 467- 471, 480.
    [14]
    TANG H, HUO Y, LYU WW, et al. Study on construction of a monitoring indicator system for traditional Chinese medicine clinical trials based on Delphi method[J]. Shanghai J Tradit Chin Med, 2024, 58( 1): 71- 76. DOI: 10.16305/j.1007-1334.2024.2306081.

    唐欢, 霍岩, 吕文文, 等. 基于德尔菲法的中医药临床试验监查指标体系构建研究[J]. 上海中医药杂志, 2024, 58( 1): 71- 76. DOI: 10.16305/j.1007-1334.2024.2306081.
    [15]
    LIU T, ZHU QH. Feasibility research on the application of likert scoring method in the evaluation of implementation effect of health standards[J]. China Health Stand Manag, 2022, 13( 16): 1- 6. DOI: 10.3969/j.issn.1674-9316.2022.16.001.

    刘拓, 朱秋鸿. Likert式计分法应用于卫生健康标准实施效果评估的可行性研究[J]. 中国卫生标准管理, 2022, 13( 16): 1- 6. DOI: 10.3969/j.issn.1674-9316.2022.16.001.
    [16]
    CHEN QS, WANG SY, DONG XM, et al. Calculation for the Delphi indices in excel[J]. J Math Med, 2004, 17( 1): 73- 76. DOI: 10.3969/j.issn.1004-4337.2004.01.039.

    陈青山, 王声湧, 董晓梅, 等. 在Excel中完成Delphi法评价指标的计算[J]. 数理医药学杂志, 2004, 17( 1): 73- 76. DOI: 10.3969/j.issn.1004-4337.2004.01.039.
    [17]
    LI JS, LI JH, LIU XN, et al. Application of Kendall’s W analysis method in medical data processing and its implementation in SPSS[J]. Mod Prev Med, 2008, 35( 1): 33, 42. DOI: 10.3969/j.issn.1003-8507.2008.01.014.

    李娟生, 李江红, 刘小宁, 等. Kendall’s W分析方法在医学数据处理中的应用及在SPSS中的实现方法[J]. 现代预防医学, 2008, 35( 1): 33, 42. DOI: 10.3969/j.issn.1003-8507.2008.01.014.
    [18]
    XU WM, HU JQ, JIANG LJ, et al. Application of analytic hierarchy process and its improvement in determining the weight of diagnostic indicators in criteria for traditional Chinese medicine syndrome[J]. Mod Tradit Chin Med Mater Med World Sci Technol, 2019, 21( 10): 2027- 2031. DOI: 10.11842/wst.20190810001.

    许伟明, 胡镜清, 江丽杰, 等. 层次分析法及其改良在确定辨证标准诊断指标权重中的应用[J]. 世界科学技术-中医药现代化, 2019, 21( 10): 2027- 2031. DOI: 10.11842/wst.20190810001.
    [19]
    LYU YH, HE YC, YANG J, et al. Study of the symptoms scale for evaluating changes in patients with coronary angina pectoris and Qi-deficiency combined with stagnation of blood in traditional Chinese medicine[J]. Chin J Clin Pharmacol Ther, 2008, 13( 7): 786- 791. DOI: 10.3969/j.issn.1009-2501.2008.07.014.

    吕映华, 何迎春, 杨娟, 等. 冠心病心绞痛(气虚血瘀证)症状疗效评分量表的研究[J]. 中国临床药理学与治疗学, 2008, 13( 7): 786- 791. DOI: 10.3969/j.issn.1009-2501.2008.07.014.
    [20]
    YUAN SL, HE Z. Nonparameter item response theory: Mokken model[J]. J Guiyang Univ Nat Sci, 2020, 15( 4): 101- 106. DOI: 10.3969/j.issn.1673-6125.2020.04.024.

    袁淑莉, 何壮. 非参数项目反应理论模型: Mokken模型[J]. 贵阳学院学报(自然科学版), 2020, 15( 4): 101- 106. DOI: 10.3969/j.issn.1673-6125.2020.04.024.
    [21]
    SUN XN, CHEN K, WU YC, et al. Development of a short version of health literacy scale: based on classical measurement theory and item response theory[J]. Chin General Pract, 2024, 27( 23): 2931- 2940. DOI: 10.12114/j.issn.1007-9572.2023.0072.

    孙小楠, 陈珂, 武运筹, 等. 简版健康素养量表的开发: 基于经典测量理论和项目反应理论[J]. 中国全科医学, 2024, 27( 23): 2931- 2940. DOI: 10.12114/j.issn.1007-9572.2023.0072.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(11)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (485) PDF downloads(37) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return